LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

Home・Lista de Ações・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Fechado

13.99

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.99

Máximo

13.99

Indicadores-chave
By Trading Economics
Rendimento	4.2M -23M
Funcionários	83
EBITDA	6.6M -23M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	-4.43% downside

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	418M 1B
Abertura anterior	13.99
Fecho anterior	13.99

Ventyx Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de mar. de 2026, 23:12 UTC

Ações em Alta

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12 de mar. de 2026, 22:15 UTC

Ganhos

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12 de mar. de 2026, 21:42 UTC

Notícias Principais

Stryker Says Cyberattack Disruption Is Continuing

12 de mar. de 2026, 21:29 UTC

Notícias Principais

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12 de mar. de 2026, 21:27 UTC

Ganhos

Adobe CEO to Depart as AI Boosts Sales -- Update

12 de mar. de 2026, 20:46 UTC

Ganhos

Adobe Posts Higher Sales With CEO Set to Depart

12 de mar. de 2026, 20:21 UTC

Notícias Principais

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12 de mar. de 2026, 23:57 UTC

Conversa de Mercado

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12 de mar. de 2026, 23:38 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 de mar. de 2026, 23:38 UTC

Conversa de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12 de mar. de 2026, 22:13 UTC

Ganhos

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12 de mar. de 2026, 22:13 UTC

Ganhos

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12 de mar. de 2026, 22:13 UTC

Ganhos

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12 de mar. de 2026, 22:13 UTC

Ganhos

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12 de mar. de 2026, 22:13 UTC

Ganhos

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12 de mar. de 2026, 22:13 UTC

Conversa de Mercado

Ganhos

Global Equities Roundup: Market Talk

12 de mar. de 2026, 22:13 UTC

Conversa de Mercado

Ganhos

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12 de mar. de 2026, 21:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12 de mar. de 2026, 21:04 UTC

Ganhos

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12 de mar. de 2026, 21:02 UTC

Ganhos

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12 de mar. de 2026, 21:02 UTC

Ganhos

Wheaton Precious Metals 4Q Sales $865M >WPM

12 de mar. de 2026, 21:02 UTC

Ganhos

Wheaton Precious Metals 4Q Net $558.3M >WPM

12 de mar. de 2026, 21:02 UTC

Ganhos

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12 de mar. de 2026, 20:57 UTC

Conversa de Mercado

Notícias Principais

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

12 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de mar. de 2026, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12 de mar. de 2026, 20:10 UTC

Ganhos

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12 de mar. de 2026, 20:05 UTC

Ganhos

Adobe 1Q Rev $6.4B >ADBE

12 de mar. de 2026, 20:05 UTC

Ganhos

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Comparação entre Pares

Variação de preço

Ventyx Biosciences Inc Previsão

Preço-alvo

By TipRanks

-4.43% parte inferior

Previsão para 12 meses

Média 13.38 USD -4.43%

Máximo 14 USD

Mínimo 9 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Ventyx Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

Comprar

Manter

Vender

Com base em 8 analistas que deram avaliações de ações para Ventyx Biosciences Inc - Dist nos últimos 3 meses.

Informação Financeira

Sobre Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.